Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in COVID-19 Patients
NCT04328272Phase 3Unknown
- Start
- Mar 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in COVID-19 pneumonia. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04328272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328272.